Using Oncology Patient Monitoring Data To Improve Outcomes
Through a grant from the National Cancer Institute (NCI), Charles River Analytics is building a platform to collect and analyze biometric sensor data and connected devices used by cancer patients across the US. The goal of the project is to support large-scale population health research and to improve cancer outcomes.
You may also be interested in...
Experts in drug development, clinical care and digital therapeutics discuss gaps in the treatment landscape for Alzheimer’s disease, as well as opportunities for prevention and innovation in care delivery.
If targeted therapies for cancer represent a more precise, laser-like attack on solid tumors and blood cancers, cytotoxic chemotherapies are more like a ham-fisted boxer punching every cell in sight. New methods for delivering chemotherapy directly into cancer cells may help to improve efficacy and reduce – or eliminate – damaging and sometimes deadly side effects.
As leader of Stanford’s Cancer Computational and Systems Biology group, Christina Curtis, one of In Vivo’s 2021 Rising Leaders, is working to shed new light on the mysteries of metastatic cancer. Curtis’s use of computational models to analyze genetic mutations in breast cancer earned her an NIH Director’s Pioneer Award.